(Press-News.org) In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain more weight and have higher risks of diabetes and hypertensive disorders during pregnancy, and experienced preterm delivery more so than people who had never taken GLP-1 drugs. The findings are published in JAMA.
“The use of glucagon-like peptide-1 receptor agonists—or GLP-1RAs—has increased dramatically, but recommendations suggest their discontinuation before pregnancy because there's not enough information about their safety for unborn babies,” said lead author Jacqueline Maya, MD, a pediatric endocrinologist at Mass General Brigham for Children. “We sought to assess how such discontinuation affects weight gain and outcomes during pregnancy.”
For the study, the team analyzed electronic health records for 1,792 pregnancies delivered within the Mass General Brigham healthcare system between 2016–2025, primarily among women with obesity. Each woman with a GLP-1RA prescription within three years before and up to 90 days after conception was matched to three similar pregnancies where the mother did not use GLP-1RAs.
Individuals who stopped GLP-1RAs before or in early pregnancy gained an average of 7.2 pounds more weight during pregnancy than those who did not use the weight loss drugs. The GLP-1RA group also had a 32% higher risk of excess weight gain (gaining more than recommended), a 30% higher risk of diabetes during pregnancy, a 29% higher risk of hypertensive disorders during pregnancy, and a 34% higher risk of preterm delivery. There were no differences in risk of high or low birth weight, birth length, or Cesarean delivery.
“Additional studies are needed on the balance of pre-pregnancy benefits of GLP-1s with the risks associated with interrupting them for pregnancy,” said senior author Camille E. Powe, MD, a Mass General Brigham endocrinologist and co-director of the Diabetes in Pregnancy Program at Massachusetts General Hospital. “We need to do more research to find ways to help manage weight gain and reduce risks during pregnancy when stopping GLP-1 medications."
Authorship: In addition to Maya and Powe, Mass General Brigham authors include Deepti Pant, Yiran Fu, Kaitlyn James, Carolina Batlle, Sarah Hsu, Diana C. Soria-Contreras, Lydia Shook, Christopher Mow, Marie-France Hivert, and Tanayott Thaweethai.
END
Patients who discontinued GLP-1s had more weight gain, complications during pregnancy
2025-11-24
ELSE PRESS RELEASES FROM THIS DATE:
Untreated sleep apnea raises risk of Parkinson’s, study finds
2025-11-24
New research reveals that people with untreated obstructive sleep apnea have a higher risk of developing Parkinson’s disease. However, they can significantly reduce the risk by improving the quality of their sleep by using continuous positive airway pressure, or CPAP.
The study, which published today in the journal JAMA Neurology, examined electronic health records covering more than 11 million U.S. military veterans who received care through the Department of Veterans Affairs between 1999 and 2022.
The research was led by Oregon Health & Science University ...
Prevalence, characteristics, and genetic architecture of avoidant/restrictive food intake phenotypes
2025-11-24
About The Study: This cohort study found that the prevalence of avoidant/restrictive food intake in the general pediatric population was substantial, and affected children had an associated elevated risk of developmental difficulties across multiple domains. The findings suggest a need for broad support interventions and advance understanding of the genetic underpinnings of avoidant/restrictive food intake.
Corresponding Author: To contact the corresponding author, Ludvig Daae Bjorndal, PhD, email l.d.bjorndal@psykologi.uio.no.
To ...
Cardiometabolic parameter change by weight regain on tirzepatide withdrawal in adults with obesity
2025-11-24
About The Study: In this post hoc analysis of the SURMOUNT-4 trial, among participants with obesity who achieved weight reduction with 36-week tirzepatide (a glucagon-like peptide-1 receptor agonist) treatment, withdrawing tirzepatide led to 25% or greater weight regain in most participants within 1 year and was associated with a greater reversal of their initial cardiometabolic parameter improvements compared with those who maintained weight reduction. These findings underscore the importance of continued obesity treatment.
Corresponding Author: To contact the corresponding author, Clare J. Lee, MD, MHS, ...
US burden of disorders affecting the nervous system
2025-11-24
About The Study: This cross-sectional study of the Global Burden of Disease 2021 study data found that, among the U.S. population of 332.7 million, disorders affecting nervous system health impacted 180.3 million U.S. individuals and were the top cause of disability. Conditions with the greatest collective disability were stroke, Alzheimer disease and
other dementias, diabetic neuropathy, and migraine. The U.S. should prioritize efforts to combat these conditions with development and implementation of new and effective prevention strategies, therapeutics, and focused rehabilitation.
Corresponding ...
Social media detox and youth mental health
2025-11-24
About The Study: In this cohort of young adults, reducing social media use for 1 week was associated with reductions in symptoms of depression, anxiety, and insomnia; however, the durability of these therapeutic outcomes and their associations with behavior warrant further study, particularly in more diverse populations.
Corresponding Author: To contact the corresponding author, John Torous, MD, MBI, email torous@bidmc.harvard.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.45245)
Editor’s Note: Please ...
One in two people in the US is affected by a neurological disease or disorder
2025-11-24
EMBARGOED FOR RELEASE AT 11 A.M. ET, MONDAY, NOVEMBER 24, 2025
Highlights:
A new systematic analysis shows more than half the people living in the U.S., 54%, are affected by a neurological disease or disorder.
Disorders of the nervous system impacted more than 180 million of the nearly 333 million Americans in 2021 and were the top cause of health loss in the U.S.
The nervous system includes the brain, spinal cord and nerves.
The most prevalent conditions were tension-type headache affecting 122 million Americans, migraine affecting 58 million and diabetic neuropathy affecting 17 million.
The leading causes of health loss were stroke, Alzheimer’s disease and ...
Colliding ribosomes signal cellular stress
2025-11-24
LMU researchers uncover the mechanism by which ribosomes raise alarms in the cell.
Ribosomes, the protein factories of the cell, are essential for all living organisms. They bind to mRNA and move along the messenger molecule, reading the genetic code as they go. Using this information, they link amino acids to make proteins. But their function goes far beyond pure production: Ribosomes are also important sensors for cellular stress and initiate protective reactions when problems arise. An international team led by Professor Roland Beckmann from LMU’s Gene Center ...
New doctoral network aims to establish optical vortex beams as key technology for advanced light-matter interaction
2025-11-24
A new Doctoral Network coordinated by Tampere University has secured €4.4 million in funding from the European Union’s Marie Skłodowska-Curie Actions (MSCA) programme. The High-Power Optical Vortices (HiPOVor) project will train 15 doctoral researchers in the generation, amplification and application of high-power optical vortex beams. The consortium has set an ambitious goal: to establish optical vortex beams as a key enabling technology for advanced light-matter interaction.
Optical vortices – light beams carrying orbital angular momentum – open up unique possibilities for ultra-precise material processing, particle acceleration, high-capacity ...
Vegan diet—even with ‘unhealthy’ plant-based foods—is better for weight loss than Mediterranean diet, finds new study
2025-11-24
WASHINGTON, D.C. — Eating a vegan diet increases consumption of plant-based foods—including those defined as “unhealthy” by the plant-based diet index—leading to greater weight loss than the Mediterranean diet, finds a new analysis by the Physicians Committee for Responsible Medicine published in Frontiers in Nutrition.
Avoiding animal products; eating foods like potatoes and refined grains, which are defined as “unhealthy” by the plant-based diet index; and avoiding added oils and nuts, which are defined as “healthy” by the plant-based diet ...
JMIR Publications joins STM and integrates STM’s Integrity Hub
2025-11-24
(Toronto, November 24, 2025) JMIR Publications, a leading publisher of academic journals dedicated to digital health and open science, today announced that it has joined the International Association of Scientific, Technical and Medical Publishers (STM), the global trade association for academic and professional publishers. In addition, JMIR Publications is integrating STM Integrity Hub into routine operations to further support the integrity and high quality of scholarly publishing and the published scientific record.
STM Integrity Hub is a platform ...